Infrainguinal Atherectomy Using the Transluminal Endarterectomy Catheter: Patency Rates and Clinical Success for 144 Procedures

Abstract

Purpose:

To determine if atherectomy using the transluminal endarterectomy catheter (TEC) is an effective endoluminal therapy for infrainguinal occlusive disease.

Methods:

Three surgeons used the TEC for 144 infrainguinal atherectomy procedures in 133 patients. The indications were severe claudication in 83, critical ischemia in 56, and graft stenosis in 5 limbs. The pathology was stenosis in 36 and occlusion in 105 limbs. Balloon dilation was also performed in 109 and stenting in 17 limbs.

Results:

There was initial technical and anatomic success in 124 (86%) procedures. There were 67 technically successful procedures at mean follow-up of 19 months, although 3 of these limbs with gangrene and extensive distal disease required major amputation. There were 26 failures due to stenosis leading to further intervention and 51 due to occlusion. Twenty of these cases were managed conservatively, 21 were treated with repeat endovascular intervention, 31 with bypass grafting, and 5 with amputation. Repeat intervention in 52 limbs resulted in 36 with patent arteries, 10that are occluded, and 6that required amputation. Thirteen of the 14 amputations were for limbs with critical ischemia, but 1 was in a patient with claudication. Life-table analysis showed that the primary patency rate was 51%, the assisted primary patency rate was 61%, and the secondary patency rate was 75% at 15 months. The clinical success rate was 49%, and the salvage rate for limbs with critical ischemia was 78% at 12 months. Univariate log-rank testing showed no significant differences according to the clinical presentation or pathology, but results were worse for lesions > 5 cm long due to more frequent immediate failures. However, multivariate Cox regression analysis showed that results were significantly worse for critical ischemia than for claudication, stenosis compared to occlusions, for limbs with poor runoff, for operations performed by percutaneous rather than an open approach, and for those performed more recently.

Conclusions:

TEC atherectomy may have a place in selected patients, but the optimal circumstances for its use and long-term efficacy require further study.

Get full access to this article

View all access options for this article.

References

Myers

Fuller

Scott

. Multivariate Cox regression analysis of covariates for patency rates after femorodistal vein bypass grafting. Ann Vasc Surg 1993;7:262–269.

Coffman

. Intermittent claudication—be conservative. N Engl J Med 1991;325:577–578.

Tunis

Bass

Steinberg

. The use of angioplasty, bypass surgery, and amputation in the management of peripheral vascular disease. N Engl J Med 1991;325:556–562.

The

SHK

Gussenhoven

Zhong

. Effect of balloon angioplasty on femoral artery evaluated with intravascular ultrasound imaging. Circulation 1992;86:483–493.

McLean

. Percutaneous peripheral atherectomy. J Vasc Intervent Radiol 1993;4:465–480.

Ahn

Eton

Moore

. Endovascular surgery for peripheral arterial occlusive disease. Ann Surg 1992;216:3–16.

Ahn

Rutherford

Becker

. Reporting standards for lower extremity arterial endovascular procedures. J Vasc Surg 1993;17:1103–1107.

Lee

. Statistical Methods for Survival Data Analysis. Belmont, California, Lifetime Learning Publications, 1980.

Benedetti

Yuen

Young

. Life tables and survivor functions. In: Dixon

, ed. BMDP Statistical Software. University of California Press, 1990:739–768.

10.

Rutherford

Flanigan

Gupta

. Suggested standards for reports dealing with lower extremity ischaemia. Prepared by the Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery/North American Chapter, International Society for Cardiovascular Surgery. J Vasc Surg 1986;4:80–94.

11.

Cox

. Regression models and life-tables. J Roy Stat Soc 1972;34:187–220.

12.

Hopkins

. Survival analysis with covariates. In: Dixon

, ed. BMDP Statistical Software. University of California Press, 1990:769–806.

13.

Wholey

Jarmolowski

. New reperfusion devices: The Kensey catheter, the atherolytic reperfusion wire device, and the transluminal extraction catheter. Radiology 1989;172:947–952.

14.

Doubilet

Abrams

. The cost of underutilization: Percutaneous transluminal angioplasty for peripheral vascular disease. N Engl J Med 1984;310:95–102.

15.

Johnston

. Femoral and popliteal arteries: Reanalysis of results of balloon angioplasty. Radiology 1992;183:767–771.

16.

Becker

Katzen

Dake

. Noncoronary angioplasty. Radiology 1989;170:921–940.

17.

Wolf

Wilson

Cross

. Surgery or balloon angioplasty for peripheral vascular disease: A randomized clinical trial. J Vasc Intervent Radiol 1993;4:639–648.

18.

Jeans

Armstrong

Cole

SEA

. Fate of patients undergoing transluminal angioplasty for lower-limb ischemia. Radiology 1990;177:559–564.

19.

Currie

Wakeley

Cole

SEA

. Femoropopliteal angioplasty for severe limb ischaemia. Br J Surg 1994;81:191–193.

20.

Murray

Hewes

White

. Long-segment femoropopliteal stenoses: Is angioplasty a boon or bust? Radiology 1987;162:473–476.

21.

London

NJM

Srinivasan

Naylor

. Subintimal angioplasty of femoropopliteal artery occlusions: The long-term results. Eur J Vasc Surg 1994;8:148–155.

22.

Johnston

. Factors that influence the outcome of aortoiliac and femoropopliteal percutaneous transluminal angioplasty. Surg Clin N Am 1992,72:843–850.

23.

Creasy

McMillan

Fletcher

EWL

. Is percutaneous transluminal angioplasty better than exercise for claudication?—preliminary results from a prospective randomised trial. Eur J Vasc Surg 1990;4:135–140.